• Denali Therapeutics (NASDAQ:DNLI) Receives Outperform Rating from William Blair

    Source: Buzz FX / 15 Jan 2025 08:30:17   America/New_York


    Denali Therapeutics (NASDAQ:DNLI) Receives Outperform Rating from William Blair Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Denali Therapeutics ( NASDAQ:DNLI - Get Free Report ) 's stock had its "outperform" ratin
    Read more...
Share on,